Sees FY25 revenue $9.13B-$9.28B, consensus $9.25B. Sees FY25 adjusted operating profit $1.91B-$1.96B. Sees FY25 adjusted operating margin 20.8%-21.2%. Sees FY25 adjusted free cash flow $1.28B-$1.33B. The company said, “We will continue to invest in ER&D and capacity expansion to support the growing needs of the industry. Our capital expenditure forecast for 2025 is ~$275 million, ~3.0% of sales.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRT:
